October 12, 2021 – The U.S. Preventive Services Task Force seeks comments on a draft recommendation statement, draft evidence review, and draft modeling report on aspirin use to prevent cardiovascular disease. People 40 to 59 should decide with their clinician whether to start taking aspirin; people 60 and older should not start taking aspirin. The draft recommendation statement, draft evidence review, and draft modeling report are available for review and public comment from October 12, 2021 to November 8, 2021 here.
